Cancer Research Program, Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society, Berlin, Germany.
Experimental Pharmacology & Oncology (EPO), Berlin, Germany.
Cancer Res. 2017 Apr 15;77(8):2134-2147. doi: 10.1158/0008-5472.CAN-15-3490. Epub 2017 Feb 15.
Many tumors display intracellular heterogeneity with subsets of cancer stem cells (CSC) that sustain tumor growth, recurrence, and therapy resistance. Cancer-associated fibroblasts (CAF) have been shown to support and regulate CSC function. Here, we investigate the interactions between CSCs and CAFs in mammary gland tumors driven by combined activation of Wnt/β-catenin and Hgf/Met signaling in mouse mammary epithelial cells. In this setting, CSCs secrete the Hedgehog ligand SHH, which regulate CAFs via paracrine activation of Hedgehog signaling. CAFs subsequently secrete factors that promote expansion and self-renewal of CSCs. treatment of tumors with the Hedgehog inhibitor vismodegib reduce CAF and CSC expansion, resulting in an overall delay of tumor formation. Our results identify a novel intracellular signaling module that synergistically regulates CAFs and CSCs. Targeting CAFs with Hedgehog inhibitors may offer a novel therapeutic strategy against breast cancer. .
许多肿瘤表现出细胞内异质性,其中癌症干细胞 (CSC) 亚群能够维持肿瘤生长、复发和治疗耐药性。已经证明癌症相关成纤维细胞 (CAF) 能够支持和调节 CSC 的功能。在这里,我们研究了 Wnt/β-catenin 和 Hgf/Met 信号通路联合激活驱动的乳腺肿瘤中 CSC 和 CAF 之间的相互作用,这种情况下,CSC 分泌 Hedgehog 配体 SHH,通过 Hedgehog 信号的旁分泌激活来调节 CAF。CAF 随后分泌促进 CSC 扩增和自我更新的因子。用 Hedgehog 抑制剂 vismodegib 治疗肿瘤可减少 CAF 和 CSC 的扩增,从而整体延迟肿瘤形成。我们的研究结果确定了一个新的细胞内信号模块,该模块协同调节 CAF 和 CSC。用 Hedgehog 抑制剂靶向 CAF 可能为治疗乳腺癌提供一种新的治疗策略。